
Topic
Specialty Pharmacy
Limited distribution, hub services, fulfillment routing, REMS friction, and payer-channel coordination.

Approvals· July 16, 2026 · 17 min read
By Ran Chen#Cardiovascular#PCSK9#FDA Approval

Approvals· July 16, 2026 · 19 min read
Revtorpyk (gedatolisib) coverage: breast cancer approval and billing
By Ran Chen#Oncology#Breast Cancer#FDA Approval

Pricing & Access· July 15, 2026 · 21 min read
COPD Access Landscape 2026: Inhaled Triple Therapy, Dupilumab, and Ensifentrine

Pricing & Access· July 15, 2026 · 19 min read
IPF Access Landscape 2026: Jascayd, Ofev Generic entry, and Pirfenidone Pricing

Policy· July 15, 2026 · 22 min read
The Post-CREATES REMS Moat Map: Safety Programs Shielding Brands After the Fix
By Ran Chen#REMS#Biosimilars#Generic Entry

Pricing & Access· July 14, 2026 · 18 min read
Generalized Myasthenia Gravis (gMG) Access and Dosing Landscape
By Ran Chen#Rare Disease#Payer Policy#HCPCS Coding

Pricing & Access· July 14, 2026 · 20 min read
PNH Access Landscape: C5 Blockers, Orals, and the Biosimilar Cliff
By Ran Chen#Rare Disease#Payer Policy#HCPCS Coding

Specialty· July 9, 2026 · 17 min read
IgA Nephropathy Access: Trutakna, Filspari, Tarpeyo, Fabhalta, and Voyxact

Specialty· July 7, 2026 · 21 min read
Voranigo (vorasidenib) Glioma Access: Pricing, Biomarker Testing, and Payer PA
By Ran Chen#Oncology#Orphan Drug#Prior Authorization

Pricing & Access· July 5, 2026 · 16 min read